Treace John T.'s Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed May 28, 2026
- Accession no.
- 0001193125-26-245341
- Filed
- May 28, 2026
- Trade date
- May 26-28, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $340.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Treace John T.CIK 0001856380 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | PPurchaseAcquired | +4,508 | $2.79 | +$12,577.32 | 7,162,821 | Direct | |
| May 27, 2026 | Common Stock | PPurchaseAcquired | +49,810 | $2.87 | +$142,954.7 | 7,212,631 | Direct | |
| May 28, 2026 | Common Stock | PPurchaseAcquired | +61,202 | $3.02 | +$184,830.04 | 7,273,833 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.